You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Bioactive Prosthetic Vascular Graft

    SBC: BIOSURFACES INC            Topic: N/A

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are comprised of either polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted in the United States each year. Medium (6-8mm) and small (l t5mm) internal diameter (I.D.) prosthetic arterial grafts continue to have unacceptably high failure rates when used in the clinical setting. T ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Accurate Protein Identification using Peptide Separation Information and Tandem M

    SBC: PREDICTIVE PHYSIOLOGY AND MEDICINE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A significant problem currently hindering proteomics studies is the identification of peptides and proteins from mass spectral data. This problem is manifest in the difficulty to establish confidence limits of protein a nd peptide identifications. A serious concern is the tendency for the occurrence of false positive assignments. The development of an integrate ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  3. A Coaxial High Energy Thruster for Defensive Space Applications

    SBC: BUSEK CO., INC.            Topic: AF07T036

    Busek Co. Inc. and Stanford University propose to develop and test an advanced high power plasma propulsion concept referred to here as a Coaxial High EnerGy Thruster, or CHENG thruster.  The thruster is first and foremost a propulsive device.  However, because the device is pulsed, compact, and efficient the plasma beam is highly condensed and energetic. For this reason, the thruster may also b ...

    STTR Phase II 2009 Department of DefenseAir Force
  4. Adaptive Hierarchical Multiple Models to Control Dynamic Systems

    SBC: SCIENTIFIC SYSTEMS CO INC            Topic: AF07T012

    Modern control theory offers mathematically rigorous and powerful solutions to many dynamic systems. Its limitations are that the classes of dynamic systems covered by the theory are limited to linear systems or certain well-structured nonlinear systems, and the adaptation of the controllers are often slow if the controller parameters are far away from their desired values. On the other hand, the ...

    STTR Phase I 2008 Department of DefenseAir Force
  5. A device containing immobilized chelator to remove aluminum from TPN solutions

    SBC: ALKYMOS, INC            Topic: N/A

    DESCRIPTION (provided by applicant): A high percentage of the ~ 470,000 children born prematurely each year in the US require intravenous feeding after birth because they do not tolerate oral feeding. This is accomplished with a total parenteral nutrition (TPN) solution, which is prepared from component solutions: small and large volume parenterals (SVPs and LVPs). Aluminum (Al) is a common conta ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Advanced infrared laser fibers

    SBC: AGILTRON, INC.            Topic: AF07T037

    This program will demonstrate, for the first time, a commercial prototype high power fiber laser in the 3-5µm band, based on Agiltron chalcogenide glass infrared optical fiber technology. High power IR lasers that emit multiwatt output at various infrared wavelengths in the 212µm region are a long-standing technical challenge. Fiber lasers, widely considered the choice for almost all high power ...

    STTR Phase II 2009 Department of DefenseAir Force
  7. Advanced Technology and Tools for DBS Programming for Speech Functionality

    SBC: Speech Technology and Applied Research Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Speech is a complex motor behavior often disrupted by neurological dysfunction. Parkinson's disease (PD) is one of the main disorders disrupting speech. Recently, deep brain stimulation (DBS) has proven to be effective for motor problems in patients with PD and other movement disorders. However, the effects of DBS on speech have not been consistently positive ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Advanced Window Materials for High Energy Propulsion

    SBC: CERANOVA CORP            Topic: AF07T009

    Window materials are an essential component of some advanced propulsion concepts which require high pressures, high temperatures, low energy losses, and low weights. Window materials must possess a combination of properties such as high mechanical strength, high melting point, high transparency, low density, and good resistance to the operating environment. CeraNova proposes the development of f ...

    STTR Phase I 2008 Department of DefenseAir Force
  9. Advanced Window Materials for High Energy Propulsion

    SBC: CERANOVA CORP            Topic: AF07T009

    CeraNova transparent polycrystalline alumina - advanced window materials for high energy propulsion.  High total transmission in the visible and the MWIR.  Submicron grains result in high hardness and strength.  High chemical resistance, thermal shock resistance, impact and erosion resistance.  Powder processing enables cost effective near-net shaping of curved parts.  Proprietary technology ...

    STTR Phase II 2009 Department of DefenseAir Force
  10. A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors

    SBC: ARISAPH PHARMACEUTICALS, INC.            Topic: 102

    DESCRIPTION provided by applicant Cancer is the second leading cause of death after heart disease in the US Chemotherapy is a mainstay of treatment after surgical removal of tumors but the balance of clinical benefit versus disabling or life threatening side effects is often uncertain Genotyping of cancers to identify mutated oncogenes has enabled an era of targeted therapy Drugs targeting ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government